fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Insulin detemir

All injection strengths: general benefit

Levemir Penfill · DIN 02271842 · 100U/mL · injection solution-5x3mL Pk

General benefitDormant since July 24, 2026 · checked October 5, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Levemir Penfill · DIN 02271842 Manufacturer: Novo Nordisk Canada Inc; listing date 2009-06-23 Health Canada: Dormant since 2026-07-24 · brand LEVEMIR PENFILL · ATC A10AE05 INSULIN DETEMIR · form Solution · route Subcutaneous · ingredients INSULIN DETEMIR 100 UNIT/ML · company Novo nordisk canada inc · schedule Schedule d
Re-check Health Canada status and shortages (live) · Health Canada product record

Levemir Penfill: Formulary list price $116.76 per unit (the source does not state the unit; exact figure $116.7600). What the ministry pays, not the patient.

Ministry pays: $116.7600 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02271842)

Source record
DIN 02271842: Levemir Penfill Raw flags: insOH=Y, sec3=Y Item: 682014007; group id 779; item number 1898; lccId None; manufacturer id NOO Source form: Inj Sol-5x3mL Pk; strength: 100U/mL Recorded listing: General benefit; diabetes medication flag Source prices (unrounded): $116.7600; ministry $116.7600 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02271842 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75736
Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02271842
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since July 24, 2026 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (A10AE): coverage varies; not interchangeable

  • Insulin degludec (Tresiba): general benefit
  • Insulin glargine (TOUJEO SoloSTAR): general benefit, limited Use 644
Other drugs in the same formulary class (68:20:14 Insulins (Long Acting)) and how they are covered

Matched class: 68:20:14 Insulins (Long Acting)

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: INSULIN DEGLUDEC Some products covered without a code (check the product listing): INSULIN GLARGINE 68:20:14 Insulins (Long Acting)

INSULIN DEGLUDEC

· 3 products · General benefit · strengths: 100U/mL, 200U/mL · Inj Sol-3X5mL Cart Pk, Inj Sol-Flextouch Pref Pen 3x3mL Pk, Inj Sol-Flextouch Pref Pen 5x3mL Pk

INSULIN GLARGINE

· 6 products · General benefit (5), Limited Use, codes 644 (1) · strengths: 300U/mL, 100U/mL · Inj Sol-1.5mL Pref Pen, Inj Sol-10mL Vial Pk, Inj Sol-3mL Pref Pen, Inj Sol-Cartridge 5x3mL Pk, Inj Sol-KwikPen (80U) Pref Pen 5x3mL Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 68:20:14
Full class listing Related classes: 68:20:02 Oral Anti-Diabetic Agents, 68:20:06 Incretin Mimetics, 68:20:10 Insulins (Rapid Acting), 68:20:12 Insulins (Intermediate Acting), 68:20:16 Insulins (Pre-Mixed) Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found

Availability

Levemir Penfill · DIN 02271842 Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02271842

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, September 10, 2026 ↗)